Mitch Zeller’s Legacy of Missed Tobacco Harm Reduction Opportunities


On April 8, Mitch Zeller punched the clock for the last time at the Food and Drug Administration (FDA), retiring after nearly a decade as director of the Center for Tobacco Products (CTP).

Just weeks later, he spoke to his former agency about his long career.

In an interview published on the FDA’s website, Zeller lauded his former colleagues. “In the face of some disappointments that we’ve experienced over the years, no one’s given up,” he said. “We lick our wounds, take a deep breath, and get on with our jobs.” He boasted that “it’s a short list” when it came to what more could have been done under his stewardship.

He was pleased that it saw the processing of some 6.7 million vaping products through the agency’s premarket tobacco product application (PMTA) pathway: The agency rejected almost all of them, and has 50,000 or so left to sort through. He wished he’d been there long enough to see the prohibition of menthol and nicotine reduction in cigarettes.

Read full article here.

Michelle Minton – Filter – 2022-04-26.

Want More Investigative Content?

Curate RegWatch
Curate RegWatch
In addition to our original coverage, RegWatch curates top stories on issues and impacts arising from the regulation of economic, social and environmental activity in Canada and the U.S.


Please enter your comment!
Please enter your name here


High Certainty | Nicotine Vapes More Effective to Help Smokers Quit...

Are e-cigarettes effective in helping smokers to quit? It’s one of the most hotly contested questions in the battle over vaping, but an answer...

Vaping Coverage Get it NOW!

Sign Up for Incisive Content!

RegWatch original video is designed to move opinion. Get our videos first and be the first to share.

Your Information will never be shared with any third party